このエントリーをはてなブックマークに追加


ID 68270
著者
Osakada, Yosuke Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID
Yunoki, Taijun Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Matsuoka, Chika Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Fukui, Yusuke Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Tsunoda, Keiichiro Department of Neurology, Tsuyama Chuo Hospital ORCID
Deguchi, Kentaro Department of Neurology, Okayama City Hospital ORCID Kaken ID publons
Morihara, Ryuta Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID researchmap
Yamashita, Toru Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID researchmap
Ishiura, Hiroyuki Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
抄録
We present a case of a male patient with disease-causing variants in SPG11, a causative gene for autosomal recessive spastic paraplegia with a thin corpus callosum (ARHSP-TCC), as well as juvenile amyotrophic lateral sclerosis (ALS5) and Charcot–Marie–Tooth disease (CMT2X). A neurological examination at age 18 revealed dysarthria, muscle weakness in bilateral lower extremities, hyperreflexia in patellar reflex, hyporeflexia in Achilles reflex with an extensor plantar reflex, and intellectual disability. Magnetic resonance imaging revealed a thin corpus callosum and ears of the lynx sign. At the age of 26, weakness and muscle atrophy progressed. While no sensory disturbances were noted, there was a mild decrease in sensory nerve action potentials of the sural nerve over the 8 years between 18 and 26. Clinicians should be aware that SPG11 belongs to the same spectrum of disorders as ALS5 and CMT2X and presents various phenotypes depending on the stage of the disease.
備考
This is the peer reviewed version of the following article: [Osakada, Y., Yunoki, T., Matsuoka, C., Fukui, Y., Tsunoda, K., Deguchi, K., Morihara, R., Yamashita, T. and Ishiura, H. (2025), Long-Term Follow-Up of a Patient With SPG11. Neurol Clin Neurosci. https://doi.org/10.1111/ncn3.12874], which has been published in final form at [https://doi.org/10.1111/ncn3.12874]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
This fulltext file will be available in Jan. 2026.
発行日
2025-01-08
出版物タイトル
Neurology and Clinical Neuroscience
出版者
Wiley
ISSN
2049-4173
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2025 Japanese Society of Neurology and John Wiley & Sons Australia, Ltd.
論文のバージョン
author
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1111/ncn3.12874
Citation
Osakada, Y., Yunoki, T., Matsuoka, C., Fukui, Y., Tsunoda, K., Deguchi, K., Morihara, R., Yamashita, T. and Ishiura, H. (2025), Long-Term Follow-Up of a Patient With SPG11. Neurol Clin Neurosci. https://doi.org/10.1111/ncn3.12874
助成機関名
Ministry of Health, Labour, and Welfare of Japan
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science
助成番号
JPMH23FC1010
JP23ek0109673
JP23K27514